Апотель

Quick links to important sections

Апотель

Selected form

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Апотель

Property Description
Active Ingredient Paracetamol (Acetaminophen)
Pharmaceutical Forms Tablets, oral solutions (syrups/granules), solution for intravenous infusion
Pharmacological Class Non-opioid analgesic and antipyretic
Common Use Pain and fever relief
WHO Status Listed on the Model List of Essential Medicines

Apotel is a widely-used medicinal product whose active component is paracetamol (acetaminophen), a substance globally recognized for its efficacy as a pain reliever (analgesic) and fever reducer (antipyretic). Paracetamol is included on the World Health Organization's List of Essential Medicines (WHO), which underscores its importance in public health systems.

The chemical structure of paracetamol classifies it as an anilide derivative. It is recognized as a medication available over-the-counter and by prescription, serving as a standard option for treating everyday aches and managing elevated body temperature.

Apotel: Key Differentiating Factors

While paracetamol is available generically, Apotel is recognized for its broad spectrum of available pharmaceutical forms. A key feature is the availability of a solution for intravenous (IV) infusion. This IV formulation serves a crucial role in hospital settings for the rapid, short-term management of pain, particularly following surgical procedures, or when oral intake is medically restricted. The brand's full range of products, including oral formats like tablets and syrups, provides flexible, patient-friendly options across different clinical needs.

Regulatory References

  1. WHO Essential Medicines List
  2. World Health Organization's List of Essential Medicines

What side effects are possible with Апотель?

Possible Side Effects and Safety Information

This section outlines the officially documented adverse reactions and safety characteristics of the active ingredient in Apotel, paracetamol (acetaminophen), based strictly on government regulatory documents.

Adverse Reactions by System and Frequency

Regulatory documentation often classifies paracetamol's adverse reactions as Rare or Very Rare at recommended doses. These effects are grouped by the affected system-organ class:

  • Blood and Lymphatic System Disorders: Includes rare reactions such as thrombocytopenia, leucopenia, and agranulocytosis.
  • Immune System Disorders: Documented hypersensitivity reactions, including angioedema and, very rarely, anaphylactic shock.
  • Skin and Subcutaneous Tissue Disorders: Reactions may include rash and urticaria. Very rare but serious cutaneous adverse reactions (SCARs), such as Stevens–Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), are explicitly listed.
  • Hepato-biliary Disorders: Reports include abnormal hepatic function and, in rare instances, hepatic necrosis or failure.

Serious Safety Considerations

Regulatory labels document the risk of severe liver damage or hepatic failure, which is primarily associated with overdose but also requires caution in individuals with pre-existing liver disease or those who chronically consume alcohol. The aforementioned severe cutaneous reactions (SCARs) are also documented as serious risks.

Population-Specific and Use Restrictions

Official safety information contains specific constraints:

  • Impaired Organ Function: Caution is mandated for patients with impaired hepatic function or impaired renal function.
  • Co-administration Constraint: Regulatory documents strictly prohibit taking Apotel with any other product containing paracetamol to prevent the risk of accidental overdose and subsequent toxicity.
  • Duration-Related Note: Prolonged regular daily use is noted as potentially increasing the risk of kidney or liver damage.

Overdose and Emergency Response

The official regulatory guidance for overdose involving Apotel (Paracetamol/Acetaminophen) mandates immediate medical attention, regardless of the initial presence or absence of symptoms. Because severe toxicity is often delayed, seeking urgent medical advice is required, even if the individual feels well.

Documented Overdose Manifestations

Initial clinical manifestations are frequently non-specific, primarily including nausea, vomiting, pallor, anorexia, and abdominal pain. These early signs may resolve, but the process leading to severe internal damage continues. Regulatory documents specify that the critical, life-threatening outcomes are acute liver failure, which can progress to hepatic encephalopathy and death, and may also involve acute renal failure. Overdose is documented to affect the hepatic, renal, and neurological systems.

Emergency Management and Risk Factors

The specific antidote, N-acetylcysteine (NAC), is required for treatment and provides maximal protection against severe hepatic injury when administered as soon as possible following ingestion. Official prescribing information identifies that the risk of severe damage is increased in patients with factors such as chronic alcoholism, severe malnutrition (glutathione depletion), and those taking enzyme-inducing medicinal products. Overdose requires urgent hospital monitoring, including measurement of plasma paracetamol concentration and continuous assessment of liver function (AST, ALT, INR).

Therapeutic Uses of Апотель

Apotel, containing acetaminophen, is commonly used in areas where short-term symptom management is appropriate to address mild to moderate pain and reduce fever. The medication is applied across domains where additional symptomatic support is needed.

Easing Discomfort and Supporting Stability

Apotel is relevant for easing symptoms related to physical discomfort stemming from conditions characterized by episodic or fluctuating manifestations. It is commonly used to help with tension headaches, dental pain, generalized muscular aches (myalgia), and cyclical menstrual cramps. This approach assists with maintaining functional stability and provides supportive relief when symptoms interfere with daily functioning.

This medication is considered relevant for its fever-reducing capability, which is often used across conditions characterized by acute or recurrent episodes of high temperature. It helps address groups of symptoms that may become intense or disruptive, such as the co-occurrence of fever, body aches, and sore throat during episodes of colds or flu. In clinical contexts, Apotel is applied when short-term symptomatic assistance is needed following minor procedures or surgery, supporting general well-being during symptomatic phases by easing the overall symptom load.


Quick Fact: Supports Management of Acute Symptoms
Apotel is commonly applied in scenarios where symptoms escalate temporarily, providing supportive relief for mild to moderate acute pain and is commonly used to help with symptoms related to systemic imbalance.

Eligibility and Restrictions for Use

Who can and cannot use Апотель

Апотель (lecanemab) is restricted to a specific population as defined by governmental regulatory documents (e.g., FDA, EMA). Use is only indicated for adult patients diagnosed with Alzheimer's disease in the early stages, specifically those with mild cognitive impairment (MCI) or mild dementia and confirmed amyloid beta pathology.


Populations Excluded or Restricted from Use

  • Contraindicated: The medicine is formally contraindicated in patients with known serious hypersensitivity to the active substance or its excipients, which may include reactions like angioedema or anaphylaxis.

  • ApoE epsilon 4 Genotype: Patients who are Apolipoprotein E epsilon 4 ( ApoE epsilon 4) homozygotes (possessing two copies of the epsilon 4 allele) have a significantly higher risk of serious Amyloid-Related Imaging Abnormalities (ARIA) and are excluded from use in certain regulatory jurisdictions, or use is strongly discouraged.

  • Concomitant Therapy: Caution is advised when considering use in patients who need to be on anticoagulant therapy or who have risk factors for intracerebral hemorrhage, such as certain findings suggestive of Cerebral Amyloid Angiopathy (CAA) on a baseline MRI scan.

  • Disease Stage: The medicine is not recommended for patients with moderate or severe dementia as efficacy has not been established in these populations. Pediatric use (under 18 years) is not established.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Apotel (Paracetamol/Acetaminophen) identifies specific drug and substance interactions that modify the medicine’s kinetics or effect. The most critical restriction is the contraindication against co-administration with any other medicinal product containing acetaminophen, which is mandated due to the severe, dose-dependent risk of acute liver failure. This heightened risk is also why the product is formally contraindicated in patients with severe hepatic impairment or severe active liver disease.

Interaction Type Interacting Substance Official Regulatory Constraint
Pharmacodynamic Warfarin and other Coumarins Enhanced anticoagulant effect occurs with prolonged regular daily use, but not with occasional dosing.
Metabolic Risk Enzyme Inducers (e.g., Carbamazepine, Phenytoin, St. John's Wort) These substances are identified as risk factors that may increase the potential for hepatotoxicity, especially at high doses.
Kinetics Metoclopramide/Domperidone Increase the speed of absorption; Cholestyramine reduces absorption.

Co-administration with Flucloxacillin carries the officially documented risk of High Anion Gap Metabolic Acidosis (HAGMA), particularly in at-risk populations. Furthermore, the regulatory labeling contains an explicit caution regarding Alcohol, stating that severe liver damage may occur if an individual consumes three or more alcoholic drinks per day while using this medication. The regulatory documents define these constraints to manage potential changes in exposure and pharmacodynamic effects during co-administration.

Mechanism of Action

Central Regulation of Body Temperature Set Point

The antipyretic mechanism engages in the hypothalamus, the brain's thermoregulatory center. Paracetamol weakly inhibits the peroxidase activity of Cyclooxygenase ( COX) enzymes, reducing the synthesis of Prostaglandin E2 ( PGE2). The reduction of this specific mediator resets the elevated temperature baseline, which facilitates the initiation of physiological heat-loss processes.

Multi-Pathway Modulation of Nociceptive Signals

Analgesia is achieved through a complex central cascade. A key paracetamol metabolite, AM404, is formed in the brain and acts as a modulator by activating TRPV1 receptors and indirectly affecting the endocannabinoid system. This targeted activity potentiates the brain's descending inhibitory pathways, thereby increasing the threshold at which nociceptive signals are processed.

Mechanistic Constraint: Peroxide Tone Dependence

The COX inhibition mechanism is effective only in the relatively low- peroxide environment of the CNS. In peripheral tissues, high concentrations of peroxides—typical of inflammation—override the drug's binding capacity. This mechanistic limitation explains why the action is constrained to central effects and does not significantly suppress the production of pro-inflammatory mediators at the site of tissue injury, which shapes its physiological profile.

Dosage and Administration Information

The administration of Апотель is governed by precise specifications detailing the approved routes, dosage limits, and timing intervals. The medicine is officially sanctioned for use via two primary methods: oral administration (tablets, solutions) and intravenous (IV) infusion (sterile solution).

For adults weighing 50 kg or more, the standard single dose ranges from 650 mg to 1,000 mg. Doses may be repeated every 4 to 6 hours as required, but a minimum interval of 4 hours must be strictly observed between consecutive administrations. Crucially, the maximum total dose from all forms of acetaminophen taken in a 24-hour period must not exceed 4,000 mg (4 grams).

Oral administration may be taken with or without food; taking the medicine on an empty stomach can accelerate the speed at which it begins to work. For the IV solution, administration is highly procedural: it must be given as a slow, controlled infusion over a period of 15 minutes. Standard protocols mandate dose and frequency adjustments for specific populations. Dosing for patients weighing less than 50 kg is determined using a weight-based regimen. Furthermore, the dosing interval must be prolonged for individuals with renal (kidney) or hepatic (liver) impairment. The medication is approved strictly for short-term symptomatic management only.

Recent Clinical Evidence

Research evidence / Overview of studies for Апотель

This section provides a transparent overview of the official research that has examined the active ingredient in Apotel (Paracetamol/Acetaminophen), focusing on what studies were conducted, what was observed, and what remains to be fully explored. This information is drawn exclusively from high-quality clinical research, systematic reviews, and regulatory summaries.


Evidence for use in Acute Symptomatic Pain Relief

The research structure for acute pain management primarily consists of numerous short-term Randomized Controlled Trials (RCTs) and large-scale Meta-Analyses. This research was applied in studies examining patient-reported outcomes describing perceived discomfort across a variety of episodic changes, such as tension headaches and dental discomfort.

Studies monitored how patient-reported symptoms evolved. Findings describe measurements recorded related to reported shifts in pain intensity, as well as the time intervals examined by researchers. The evidence structure focuses on the acute management of symptoms over short observation periods, and long-term outcomes are not well characterized by this research.


Evidence for use in Fever Reduction (Antipyresis)

Research for fever reduction was evaluated in numerous Randomized Controlled Trials, with a particular focus on conditions involving periods of heightened symptoms and outcomes related to systemic imbalance. The research foundation relies on RCTs to evaluate physiological changes in subjects with elevated body temperature, often comparing the medication against an inactive substance or other pharmacological options. Research describes that findings indicate data points related to the temperature outcomes measured during the study period. What remains uncertain is whether this medication affects the underlying condition causing the fever, or if its research applies only to symptomatic measurements.


Evidence in Special Populations

The research landscape has specifically evaluated the use of this medication across different age groups, including general Adult populations and Pediatric populations (infants and children). However, research exploring its use in certain highly complex comorbidity-defined groups or in specific phases of pregnancy is not always as well-characterized as in the general adult and pediatric populations.

Key Studies & References

  1. WHO Model List of Essential Medicines (23rd list)
  2. Acetaminophen Drug Information (MedlinePlus, U.S. National Library of Medicine)
  3. Multimodal Pain Management in Postoperative Care (Review, NIH/PMC)

Frequently Asked Questions (FAQ)

Common questions about Апотель (FAQ)


Q: Is Апотель the same type of medicine as [Commonly confused drug]? What's the difference?

Апотель is classified in regulatory documents as a non-opioid medicine for pain and fever relief (analgesic and antipyretic). Official mechanistic descriptions state that unlike some other pain relievers, this medicine primarily works in the central nervous system (the brain and spinal cord). This means it typically does not reduce inflammation in the body's tissues outside of the CNS.

Q: Can Апотель cause any long-term health issues?

Regulatory documents include a specific warning that prolonged regular daily use may increase the potential risk of damage to the kidney or liver. Severe liver damage or hepatic failure is the most serious safety concern associated with the medicine, particularly in cases of overdose.

Q: Are there any specific foods or drinks that should be avoided when using Апотель?

Official product information advises specific caution regarding alcohol consumption. Documents state that severe liver damage may occur if a person consumes three or more alcoholic drinks per day while using this medication. In contrast, the medicine can generally be taken with or without food.

Q: Why is it important to tell my doctor about all my other supplements before starting Апотель?

Official regulatory documents indicate that certain herbal products or other supplements can potentially interact with the active ingredient. This interaction may either increase the potential for liver-related toxicity or change how the medicine is processed by the body (e.g., enzyme induction).

Q: Has Апотель been approved for use in children or adolescents?

Official prescribing information indicates the medication is approved for use in children aged 6 years and older, with dosing typically determined using a weight-based regimen. Regulatory documents describe that use in children younger than 6 years old is managed under the guidance of a healthcare professional.

Q: Is it true that Апотель can interact with certain herbal products?

Yes, regulatory information identifies specific herbal products that may interact. For example, some official documents list St. John's Wort as a substance that may increase the risk of hepatotoxicity (liver damage) when combined with this medicine.

Q: What does 'contraindicated' mean in the context of Апотель?

In official medical documents, 'contraindicated' describes a situation where the medication should be avoided because the risks are considered to outweigh any possible benefits under those specific conditions. Examples of contraindications for this medicine include severe active liver disease or simultaneously taking any other product that contains its active ingredient.

Q: Can someone who is pregnant or breastfeeding use Апотель?

Regulatory guidance, based on extensive historical data, confirms the active ingredient can be used during pregnancy when there is a clinical need. The guidance describes that it is generally used at the lowest effective dose for the shortest possible duration. Furthermore, the medicine is compatible with breastfeeding when used at normal doses.

Q: Where can I find the official summary of product characteristics (SmPC) for Апотель?

The official summary of product characteristics (SmPC) is available via government drug regulatory bodies. These comprehensive documents can be found on the websites of authorities such as the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) in the form of prescribing information.

Q: Why do some people report feeling no effect from Апотель?

The analgesic action is achieved through a complex central mechanism within the brain and spinal cord. Official descriptions of the medicine's mode of action show it has limited activity in inflamed peripheral tissues. This mechanistic limitation is cited as a reason for variability in perceived relief for some pain types.

Q: How quickly should a person expect to notice the effects of Апотель?

Official data indicates that the onset of action typically occurs within 15 to 30 minutes after taking the oral formulation. The expected duration of its pain-relieving effect usually lasts for about four to six hours, based on pharmacological studies.

Q: What kind of common over-the-counter pain relievers can interact with Апотель?

Regulatory documents discuss the use of the active ingredient in combination with other non-prescription pain relievers. Studies have examined its co-administration with non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, noting that the combination has been observed to provide symptomatic relief.

Q: Is it common for people to feel tired or dizzy after starting Апотель?

Official product information for the single-ingredient formulation does not typically list side effects like dizziness or sleepiness as common occurrences. These types of central nervous system effects are more frequently reported in products where this medicine is combined with other active ingredients.

Q: Is Апотель known to be habit-forming or addictive?

The medicine is officially classified as a non-opioid analgesic and antipyretic. In the single-ingredient formulation, official regulatory documents do not contain statements listing the risk of physical dependence or addiction.

Q: Can Апотель be used by older adults (e.g., people over 65)?

Appropriate studies have not identified specific problems that would limit the use of this medication in the elderly population. However, some clinical guidelines describe that the maximum total daily dose is sometimes reduced for older patients, for example, to 3,000 mg or less, due to age-related changes.

Q: Is it safe to drive or operate machinery while using Апотель?

Official labeling for the single-ingredient product does not contain specific warnings prohibiting driving or operating heavy machinery. However, if a person experiences any side effects that could affect their concentration or motor skills, caution is generally warranted.

Q: Does the time of day matter when someone uses Апотель?

The official administration requirements are governed by maintaining the minimum time interval required between consecutive doses (4 to 6 hours) to prevent accidental overdose. The time of day the medicine is taken is less important than respecting this minimum interval.

Q: Is it okay to have coffee or caffeine while using Апотель?

Official drug interaction checkers and research show no significant interaction between the medicine and caffeine. In fact, the active ingredient is often combined with caffeine in some commercial over-the-counter products.

Q: Is there a generic version of Апотель available?

Yes, the active ingredient in Апотель, paracetamol (or acetaminophen), is one of the most widely available generic substances globally. It is listed on the World Health Organization’s Model List of Essential Medicines.

Q: Does Апотель help with all symptoms related to the condition it treats?

The research base for the medicine primarily focuses on its role in providing symptomatic measurements of relief for pain and fever. Official documents do not contain claims stating that the medicine treats or cures the underlying disease or condition causing those symptoms.

Q: Is Апотель available without a prescription in some countries?

Yes, the drug is made available as both an over-the-counter (OTC) medication, meaning it can be purchased without a prescription, and as a prescription-only product in different regulatory jurisdictions.

Q: Does Апотель affect sleep patterns?

Official prescribing information for the single-ingredient product does not list changes to sleep patterns, such as sleepiness or insomnia, as a common side effect.

How should Апотель be stored and disposed of?

How to Store and Dispose of Apotel (Paracetamol IV Solution)

The official storage and disposal requirements for Apotel are strictly defined by regulatory agencies to maintain the drug's stability and efficacy.

️ Storage Requirements

Condition Requirement Constraint
Temperature Do not store above 30 C (86 F) Do not refrigerate or freeze
Light Protection Keep the container in the outer carton Protect from light
Container Type For single use only Discard all unused solution

⏳ Stability and Handling

The unopened solution has a shelf-life of 2 years. After opening the container or connecting the giving set, the infusion must commence immediately. If the solution is diluted, it must be used within one hour of preparation, including the total infusion time.

️ Disposal Rules

Any unused solution must be discarded immediately after use. As a non-hazardous medicine, it may generally be disposed of in household trash after being mixed with an undesirable substance (e.g., used coffee grounds) and placed in a sealed bag, following general government guidelines for unused medication disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Апотель found in:

A-Z Index: